Evotec SE (EVO) Non Operating Income (2009 - 2025)
Evotec SE's (EVO) quarterly Non Operating Income came in at $1.8 million in Q3 2025, up 108.05% year-over-year from $866450.1 in Q3 2024, and up 117.41% quarter-over-quarter from -$10.4 million in Q1 2025.
Analysis
Evotec SE (EVO) Non Operating Income (2009 - 2025) Analysis & Trends
Evotec SE has disclosed Non Operating Income across 8 years of filings, most recently posting $1.8 million for Q3 2025.
- In Q3 2025, Non Operating Income rose 108.05% year-over-year to $1.8 million; the TTM figure through Sep 2025 stood at -$40.2 million (up 86.67% YoY), while the FY2022 annual figure was -$184.2 million, down 179.44% from the prior year.
- Non Operating Income came in at $1.8 million for Q3 2025 at Evotec SE, up from -$10.4 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $144.6 million in Q3 2021 to a low of -$300.4 million in Q4 2022.
- Average Non Operating Income over 4 years is -$14.6 million, with a median of -$9.8 million recorded in 2024.
- Year-over-year, Non Operating Income surged 1499.68% in 2021 and slumped 701.01% in 2022.
- Over 4 years, Non Operating Income stood at -$37.5 million in 2021, then tumbled by 701.01% to -$300.4 million in 2022, then jumped by 92.55% to -$22.4 million in 2024, then surged by 108.05% to $1.8 million in 2025.
- Per Business Quant data, the three most recent Non Operating Income figures were $1.8 million in Q3 2025, -$10.4 million in Q1 2025, and -$22.4 million in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 4.84 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | - |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | - |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 12,401.60 |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | 1.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | -10.35 Mn |
| Sep 30, 2024 | -22.38 Mn |
| Mar 31, 2024 | -9.31 Mn |
| Dec 31, 2022 | -300.36 Mn |
| Sep 30, 2022 | 30.08 Mn |
| Jun 30, 2022 | -21.95 Mn |
| Mar 31, 2022 | -77.66 Mn |
| Dec 31, 2021 | -37.50 Mn |
| Sep 30, 2021 | 144.64 Mn |
| Jun 30, 2021 | 70.39 Mn |
| Mar 31, 2021 | 57.49 Mn |
| Dec 31, 2020 | -8.08 Mn |
| Sep 30, 2020 | -10.33 Mn |
| Dec 31, 2019 | -7.07 Mn |
| Sep 30, 2010 | 242,759.25 |
| Jun 30, 2010 | 67,566.39 |
| Mar 31, 2010 | 160,626.34 |
| Dec 31, 2009 | -2.31 Mn |
| Jun 30, 2009 | 369,006.69 |